Publications by authors named "Chufeng Zeng"

Claim this Profile
C
CCL5 Macrophages Interact with CD8 T Cells and Potentiate Responsiveness to PD-1 Blockade Plus Chemotherapy in Esophageal Squamous Cell Carcinoma.
Yuanzhen Ma, Xiaodong Su, Tingting Zeng, Chunlian Zhou, Guozhen Yang, Zengfei Xia, Chufeng Zeng

Adv Sci (Weinh)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal CT and MRI Radiomics Integrated with Clinical Models Predict Pathological Complete Response in ESCC Following Neoadjuvant Immunochemotherapy.
Longgao Liu, Chufeng Zeng, Lizhi Liu, Shumin Zhou, Weihua Wu

Tomography· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma with non-regional cervical lymph node metastasis: a retrospective pilot study.
Chufeng Zeng, Guozhen Yang, Lingyu Tan, Kun Li, Wenyu Zhai

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Anastomotic Leaks on Long-Term Survival in Patients with Esophageal Squamous Cell Carcinoma Following McKeown Esophagectomy: A Propensity Score-Matched Analysis.
Chufeng Zeng, Xu Zhang, Bei Jia, Yi Hu, Peng Lin

Ann Surg Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: Anastomotic Leaks as a Surrogate of Biologic Vulnerability in Esophageal Squamous Cell Carcinoma Survival.
Chufeng Zeng, Xu Zhang, Bei Jia, Yi Hu, Peng Lin

Ann Surg Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesterol Metabolism-related Characteristics Predict Therapeutic Response and Survival in Esophageal Cancer.
Lingyu Tan, Xiaodong Su, Yuanzhen Ma, Chufeng Zeng, Haodong Yue, Tingting Zeng

J Adv Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Watch-and-wait strategy in resectable esophageal cancer following neoadjuvant chemoimmunotherapy: a case series.
Lingyu Tan, Guozhen Yang, Chufeng Zeng, Xu Zhang

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the interval between neoadjuvant immunotherapy and surgery on prognosis in esophageal squamous cell carcinoma (ESCC): a real-world study.
Guozhen Yang, Yutong Hong, Xiaomin Zhang, Chufeng Zeng, Linyu Tan

Cancer Immunol Immunother· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of neoadjuvant chemotherapy or chemoradiotherapy plus immunotherapy for locally resectable esophageal squamous cell carcinoma.
Guozhen Yang, Haodong Yue, Xiaomin Zhang, Chufeng Zeng, Linyu Tan

Front Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis